A study of neoadjuvant sintilimab combined with chemotherapy TP for locally advanced esophageal squamous cell carcinoma (ESCC).

被引：0
|
作者：
Li, Zhao
Xu, Peng-Fei
Mao, Wei-Min
Kuang, YuKang
Fan, Hai-Yin
Zou, Bin
Zhu, Jian-Feng
Li, Chao
Cheng, Xiao-Liang
Liu, Xing-Fei
Guo, Changying
机构：
[1] Jiangxi Prov Tumor Hosp, Nanchang, Peoples R China
[2] Nanchang Univ, Jiangxi Prov Tumor Hosp, Med Coll, Nanchang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16038
引用
收藏
页码：E16038 / E16038
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study
    Yang, Peng
    Zhou, Xiao
    Yang, Xuefeng
    Wang, Yuefeng
    Sun, Tao
    Feng, Shiying
    Ma, Xianyou
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [32] Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study
    Peng Yang
    Xiao Zhou
    Xuefeng Yang
    Yuefeng Wang
    Tao Sun
    Shiying Feng
    Xianyou Ma
    World Journal of Surgical Oncology, 19
  • [33] Anlotinib combined with paclitaxel and cisplatin as neoadjuvant treatment for esophageal squamous cell carcinoma (ESCC).
    Jiang, Gongqian
    Wang, Guolei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 409 - 409
  • [34] Recombinant human-endostatin combined with sintilimab and chemotherapy in first-line treatment of locally advanced or metastatic esophageal squamous cell carcinoma
    Cui, Shiyun
    Fan, Lei
    Sun, Xinnan
    Cai, Yucheng
    Wang, Ting
    Li, Ping
    Wang, Rong
    Liu, Lianke
    ONCOLOGY LETTERS, 2025, 29 (05)
  • [35] Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma
    Wang, Zhen
    Chen, Xiankai
    Li, Yong
    Qin, Jianjun
    Fang, Yuan
    Yang, Zhaoyang
    Fang, Yan
    Qu, Dong
    Zhang, Ruixiang
    Zheng, Qingfeng
    Kang, Xiaozheng
    Xue, Liyan
    Huang, Jing
    Li, Yin
    He, Jie
    JOURNAL OF THE NATIONAL CANCER CENTER, 2022, 2 (02): : 98 - 105
  • [36] Neoadjuvant anlotinib combined with penpulimab for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Updated data from a prospective, phase II trial
    Chen, Yueyun
    Yuan, Yong
    Yang, Yu-Shang
    Lin, Zhen
    Tian, Jiangfang
    Liu, Ting
    Yue, Zheng
    Shi, Hua-Shan
    Hu, Yang
    Ding, Zhen-Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Neoadjuvant sintilimab, albumin-bound paclitaxel, and carboplatin for locally advanced resectable esophageal squamous cell carcinoma: A prospective phase 2 study
    Jiang, Haiping
    Ye, Peng
    Li, Ning
    Wu, Hui
    Ding, Yongfeng
    Xu, Xin
    Ma, Ying
    Teng, Xiao-Dong
    Ji, Songxiao
    Li, Jingjie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Impact of immunotherapy combined with neoadjuvant chemotherapy or chemoradiotherapy on perioperative safety in locally advanced esophageal squamous cell carcinoma (LA-ESCC): A retrospective propensity score-matched analysis
    Xin, Li Yi
    Xiao, Gang
    Yang, Bo
    Hong, Yidan
    Gu, Lingling
    Kong, Cheng
    Zhao, Lijun
    Zhu, Zihao
    Xu, Qicen
    Chen, Yu
    Jiang, Ming
    Zhu, Xiangzhi
    Jiang, Ning
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] Two cycles versus four cycles of neoadjuvant camrelizumab plus chemotherapy in patients with locally advanced esophageal squamous cell carcinoma (ESCC): A prospective, multicenter and randomized study.
    Zhang, Qin
    Cao, Guochun
    Fan, Zhaohui
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 350 - 350
  • [40] Does the time interval from neoadjuvant camrelizumab combined with chemotherapy to surgery affect outcomes for locally advanced esophageal squamous cell carcinoma?
    Liu, Jiacong
    Zhu, Linhai
    Huang, Xuhua
    Lu, Zhongjie
    Wang, Yanye
    Yang, Yuhong
    Ye, Jiayue
    Gu, Chen
    Lv, Wang
    Zhang, Chong
    Hu, Jian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (03)
12345